Variant Bio, a genomics-driven AI drug discovery company, today announced the appointment of Craig T. Basson, MD, PhD, as Chief Medical Officer and President of R&D. Dr. Basson brings more than 25 ...
Georgia Tech’s vision of an 18-acre innovation district for medical and technology startups is beginning to become a reality. The research university and its development partners held a groundbreaking ...
Artificial intelligence-powered protein design promises to transform fields ranging from drug discovery to industrial materials development. But design only gets you so far – every invention also has ...
HONG KONG SAR - EQS Newswire - 30 December 2025 - Uni-Bio Science Group Limited ("Uni-Bio Science Group", "Uni-Bio" or "the Group") is pleased to announce the official signing of a tripartite ...
A rendering of buildings planned for the downtown Research and Development District. Courtesy of IQHQ/Transparent House Premier biotech companies, investors, and industry talent from all over the ...
The decentralized science DAO supports healthcare efforts that might otherwise not attract sufficient funding and gives stakeholders a say in their management. BIO Protocol supports a network of ...
Belite Bio's lead drug, Tinlarebant, targets eye diseases STGD1 and GA, showing promising results but with delayed phase 3 trial data expected by late 2024 or early 2025. Tinlarebant works by reducing ...
Jul. 31, 2025 9:56 PM ETBio-Rad Laboratories, Inc. (BIO) Stock, BIO.B StockAI-Generated Earnings Calls Insights ...
The Delhi High Court has rejected a plea by Japanese firm Hirotsu Bio Science Inc challenging the dismissal of its patent ...
Student has earned at least 30 semester hours (AP, Post Secondary, Transfer, IB, etc.), including ENG 111, Miami Plan Foundation IIA-Creative Arts, Foundation IIB-Humanities, Miami Plan Foundation IIC ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback